| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/03/2010 | CN101641374A Binding members for interleukin-6 |
| 02/03/2010 | CN101641373A Antibodies specific for DKK-1 |
| 02/03/2010 | CN100586960C HAb18GC2 monoclonal antibody and its light and heavy chain variable area genes, and application |
| 02/03/2010 | CN100586481C Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 02/02/2010 | US7657380 Methods of generating variant antibodies with increased host string content |
| 02/02/2010 | US7655783 Methods and compositions for increasing antibody production |
| 02/02/2010 | US7655771 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 02/02/2010 | US7655765 Modified Fc molecules |
| 02/02/2010 | US7655764 immunoglobulin domain peptides having myostatin, erythropoietin or thrombopoietin peptides as an internal sequence, preferably in a loop region of the domain; antibodies |
| 02/02/2010 | US7655763 Neutralizing antibodies against GDF-8 and uses therefor |
| 02/02/2010 | US7655762 Monoclonal antibodies against ANGPTL4 |
| 02/02/2010 | US7655761 IL-17-like cytokine binding compounds and antibodies |
| 02/02/2010 | US7655760 Antibodies to the polypeptide hormone phosphatonin |
| 02/02/2010 | US7655759 Recombinant bivalent monospecific immunoglobulin having at least two variable fragments of heavy chains of an immunoglobulin devoid of light chains |
| 02/02/2010 | US7655755 Breast cancer resistance protein (BCRP) and the DNA which encodes it |
| 02/02/2010 | US7655752 TNF-α converting enzyme inhibitory agents and method of using same |
| 02/02/2010 | US7655751 An EGFR-reactive cytotoxic T lymphocyte which recognizes a complex between the EGFR-derived peptide and human leukocyte antigen (HLA) molecule; anticarcinogenic agent |
| 02/02/2010 | US7655634 Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis |
| 02/02/2010 | US7655617 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 02/02/2010 | US7655616 Traumatic brain and spinal cord injury treatment; administering interleukin-1B converting enzyme (capsase-1) inhibitor |
| 02/02/2010 | US7655472 compositions and methods to suppress the activation and/or proliferation of mesenchymally derived cells, as well as cells with abnormal growth characteristics; inhibit or eliminate fibrosis; cancer |
| 02/02/2010 | US7655463 Treating neuropathic pain, particularly diabetic peripheral neuropathy, by administering a truncated neublastin polypeptide; activating a RET receptor tyrosine kinase |
| 02/02/2010 | US7655458 Endostatin for use in the treatment of cancer and tumor metastasis |
| 02/02/2010 | US7655444 Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents |
| 02/02/2010 | US7655438 Antisense polynucleotide; cancer; polypeptide comprising the protein encoded by the polynucleotide sequence |
| 02/02/2010 | US7655432 Nucleotide sequences coding serine/threonine kinase for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 02/02/2010 | US7655429 biological conjugate drug; used in immunodiagnostic assays to compete with topiramate for anti-topiramate antibodies; competitive bonding; finding the right dosage of anti-epileptic drug for each patient |
| 02/02/2010 | US7655427 Immunogenic proteins of Leptospira |
| 02/02/2010 | US7655426 Ephrin-B receptor protein involved in carcinoma |
| 02/02/2010 | US7655425 Uses of a chemokine receptor able to bind to MCP-1, MIP-1α and/or RANTES |
| 02/02/2010 | US7655422 Using g-protein coupled receptor as tools in identifying modulators which improve palatability of low-calorie beverages through development of new artificial sweeteners |
| 02/02/2010 | US7655418 Identifying modulators of preferential lyase for use as tool in controlling crop pests; biological pest control; disease resistant plants |
| 02/02/2010 | US7655417 VCAM-1 specific monoclonal antibody |
| 02/02/2010 | US7655412 Useful to form complexes having an affinity to targets of interest; verotoxin subunit B |
| 02/02/2010 | US7655410 Using concentration of human luteinizing hormone (hLH) to prognose and predict onset of menopause; evaluating efficacy of hormone replacement therapy |
| 02/02/2010 | US7655408 PCA3 messenger RNA species in benign and malignant prostate tissues |
| 02/02/2010 | US7655246 Chlamydia protein, gene sequence and uses thereof |
| 02/02/2010 | US7655239 Peptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 02/02/2010 | US7655234 Inhibiting growth of a solid tumor cell that expresses the protein; cancer diagnosis |
| 02/02/2010 | US7655232 Monoclonal antibody for use in prevention and treatment of osteoarthritic and surgical pain; immunotherapy |
| 02/02/2010 | US7655231 Methods for treating pain by administering a nerve growth factor antagonist and an NSAID |
| 02/02/2010 | US7655230 Co-administration of a tissue plasminogen activator, anti-CD11b antibody and anti-CD18 antibody in stroke |
| 02/02/2010 | US7655228 Ganglioside (GD3) specific immunoglobulin for diagnosis, prevention and treatment of cell proliferative disorders |
| 02/02/2010 | US7655227 Using a substance capable of inhibiting the binding between parathyroid hormone-related peptide (PTHrP) and a receptor; humanized anti-parathyroid hormone related protein 1-34 (anti-PTHrP (1-34)) antibody |
| 02/02/2010 | US7655223 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 02/02/2010 | CA2585164C Nucleotides sequences derived from the genome of type hiv-1, hiv-2 and siv retroviruses, and their applications especially for the amplification the genomes of these retroviruses and for in vitro diagnosis of infections due to these viruses |
| 02/02/2010 | CA2479494C Compositions and methods associated with pro5725 and its use for the diagnosis of lung and colon tumor |
| 02/02/2010 | CA2459489C Method for diagnosing or monitoring carbohydrate metabolism disorders |
| 02/02/2010 | CA2439051C Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 02/02/2010 | CA2428214C Methods for generating genetically altered antibody-producing cell lines with improved antibody characteristics |
| 02/02/2010 | CA2426043C Modulating angiogenesis |
| 02/02/2010 | CA2387473C Improved method for the detection of acid resistant microorganisms in a stool |
| 02/02/2010 | CA2366468C Anti-human mitochondrial adenylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease |
| 02/02/2010 | CA2355893C Antiuracil monoclonal antibody |
| 02/02/2010 | CA2293724C Apaf-1, the ced-4 human homolog, an activator of caspase-3 |
| 02/02/2010 | CA2272573C Peptide derived from an antigen recognized by autoantibodies from patients with rheumatoid arthritis, antibody directed against said peptide, a combinatorial antigen, and a methodof detecting auto-immune antibodies |
| 02/02/2010 | CA2239237C Chromatographic method for high yield purification and viral inactivation of antibodies |
| 02/02/2010 | CA2180425C Purified primate ctla-8 antigens and related reagents |
| 02/02/2010 | CA2160937C Survival motor neuron (smn) gene: a gene for spinal muscular atrophy |
| 02/02/2010 | CA2146974C Direct selection of cells by secretion product |
| 02/02/2010 | CA2142331C Immunoglobulins devoid of light chains |
| 01/28/2010 | WO2010011999A2 Methods and compositions for eliciting an amyloid-selective immune response |
| 01/28/2010 | WO2010011947A2 AMYLOID ß PEPTIDE ANALOGUES, OLIGOMERS THEREOF, PROCESSES FOR PREPARING AND COMPOSITIONS COMPRISING SAID ANALOGUES OR OLIGOMERS, AND THEIR USES |
| 01/28/2010 | WO2010011697A1 Structural variants of antibodies for improved therapeutic characteristics |
| 01/28/2010 | WO2010011357A2 Detection of prostate cancer using psa glycosylation patterns |
| 01/28/2010 | WO2010011337A1 Methods and compositions for discovery of target-specific antibodies using antibody repertoire array (ara) |
| 01/28/2010 | WO2010010549A2 Methods of altering peripheral b cell populations and uses thereof |
| 01/28/2010 | WO2010010466A2 Neutralizing anti-influenza a virus antibodies and uses thereof |
| 01/28/2010 | WO2010010178A1 The tuberculosis rv2707c protein, compositions and uses thereof |
| 01/28/2010 | WO2010010119A1 Amino acid sequences directed against multitarget scavenger receptors and polypeptides |
| 01/28/2010 | WO2010010055A1 Lawsonia intracellularis bacterium of a novel serotype, vaccine based on that bacterium, antibodies suitable for diagnosing the novel lawsonia intracellularis serotype and hybridomas for producing the said antibodies |
| 01/28/2010 | WO2010009987A2 Diagnostic antibody assay |
| 01/28/2010 | WO2009147530A3 Conformation specific antibodies that bind trefoil factors |
| 01/28/2010 | WO2009147201A3 Anti-inflammatory agents |
| 01/28/2010 | WO2009137113A3 Peptides, antibodies, and uses thereof for identifying and targeting provasopressin-expressing cancer cells |
| 01/28/2010 | WO2009135861A3 Humanized antibodies against human interferon-alpha |
| 01/28/2010 | WO2009129173A3 Methods, antibodies and kits for detecting cerebrospinal fluid in a sample |
| 01/28/2010 | WO2009124931A3 Single variable domains against the notch pathways |
| 01/28/2010 | WO2009090656A3 Combination therapy of beta-glycolipids and antibodies for the treatment of immune-related disorders |
| 01/28/2010 | WO2006020326A9 Methods of identifying compounds that modulate protein activity |
| 01/28/2010 | US20100024077 Ce44-69d insecticidal cotton |
| 01/28/2010 | US20100024049 Digestive System Cancer Stem Cells and Tests and Uses Therefor |
| 01/28/2010 | US20100022760 Mutant protein |
| 01/28/2010 | US20100022756 Trimerising Module |
| 01/28/2010 | US20100022615 Activated cytotoxic compounds for attachment to targeting molecules for the treatment of mammalian disease conditions |
| 01/28/2010 | US20100022454 Peptides with High Affinity for the Prolactin Receptor |
| 01/28/2010 | US20100022029 Homocysteine immunoassay |
| 01/28/2010 | US20100022028 Human ox2 receptors |
| 01/28/2010 | US20100021996 Genetically Altered Anti-body Producing Cell Lines With Improved Antibody Characteristics |
| 01/28/2010 | US20100021995 Biological products |
| 01/28/2010 | US20100021976 Production of polyunsaturated fatty acids, novel biosynthesis genes, and novel plant expression constructs |
| 01/28/2010 | US20100021935 Goodpasture Antigen Binding Protein and Its Detection |
| 01/28/2010 | US20100021934 Perlecan Fragments as Biomarkers of Bone Stromal Lysis |
| 01/28/2010 | US20100021918 Method for assaying action of antitumor agent using splicing defects as index |
| 01/28/2010 | US20100021496 Methods, kits, and antibodies for quantitative determination of parathyroid hormone molecules with intact c-terminus |
| 01/28/2010 | US20100021492 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 01/28/2010 | US20100021489 comprising an RNA sequence capable of specifically binding a polypeptide participating in influenza virus infection of cells |
| 01/28/2010 | US20100021484 Compositions, Methods and Kits Relating to Poxvirus Subunit Vaccines |
| 01/28/2010 | US20100021483 Humanized anti-5t4 antibodies and anti-5t4/calicheamicin conjugates |
| 01/28/2010 | US20100021481 Conjugates of an anti-tnf-alpha antibody |